Skip to content
2000
Volume 25, Issue 15
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873
file format pdf download PDF
file format text download EPUB
side by side viewer icon HTML

Abstract

Background

CBC (complete blood count) tests, along with RPM (Renal parameters) and LFT (Liver function tests), are clinically important for coronavirus patients; curcumin can serve as a possible treatment for SARS- CoV.

Objective

The objective of the study was to determine the relationship of CBC parameters with renal parameters and liver function tests and to develop the hypothesis that curcumin may be the best and non-invasive drug for coronavirus.

Materials & Methods

The differences between the results of 91 confirmed cases of COVID-19 (symptomatic and asymptomatic) and 100 controls were assessed by an independent t-test and Mann-Witney U Wilcoxon test. Microscopy, hematological tools, and techniques were used to assess the improvements/abnormalities in blood components and parameters.

Results

This is a case control study along with the feasibility of curcumin as COVID treatment. The association between parameters was assessed by Pearson & Spearman correlation analysis. The level of significance was < 0.05. Changes were observed in urea ( = 0.000), creatinine ( = 0.02), total bilirubin ( = 0.000), SGPT (ALT) ( = 0.000), RBC ( = 0.001), HGB ( = 0.001), MCV ( = 0.002), MCH ( = 0.03), MPV, PDW, NE%, LY%, and MO% EO% ( = 0.00), in comparison to normal controls. Differences in the correlation of electrolytes, RPM, and LFT tests along with CBC parameters in Pakistani and Chinese individuals provided a new idea for using various diagnostic and therapeutic tools in different ethnic groups. The COVID-19 infected blood components and parameters showed rapid improvement/recovery, especially the total count of platelets and WBCs (lymphocytes and basophils), HGB, HCT, MCV, and MCH.

Conclusion

Curcumin drugs can be used as an immediate remedy/treatment to cure COVID-19 patients.

© 2025 The Author(s). Published by Bentham Science Publishers.
This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/emiddt/10.2174/1871530323666230314121123
2025-07-10
2026-02-28

  • From This Site

    /content/journals/emiddt/10.2174/1871530323666230314121123
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/emiddt/25/15/EMIDDT-25-15-06.html?itemId=/content/journals/emiddt/10.2174/1871530323666230314121123&mimeType=html&fmt=ahah

References

  1. ZhangT. WuQ. ZhangZ. Probable pangolin origin of SARS- CoV-2 associated with the COVID-19 outbreak.Curr. Biol.2020308157810.1016/j.cub.2020.03.06332315626
     [Google Scholar]
  2. Worldometer, Coronavirus Cases. 2020Available from: https://www.worldometers.info/coronavirus/
  3. AliI. ShahS.A. SiddiquiN. Pakistan confirms first two cases of coronavirus, govt says “no need to panic”.Dawn.com.2020226Available from: https://www.dawn.com/news/153 6792#:~:text=Yesterday%2C%20the%20Sindh%20health%20department, cases%20of%20coronavirus%20in%20Pakistan
    [Google Scholar]
  4. ChiappiniE. SantamariaF. MarsegliaG.L. MarchisioP. GalliL. CutreraR. de MartinoM. AntoniniS. BecherucciP. BiasciP. BortoneB. BotteroS. CaldarelliV. CardinaleF. GattinaraG.C. CiarciàM. CiofiD. D’EliosS. Di MauroG. DoriaM. IndinnimeoL. Lo VecchioA. MacrìF. MattinaR. MinielloV.L. del GiudiceM.M. MorbinG. MotisiM.A. NovelliA. PalamaraA.T. PanattaM.L. PasinatoA. PeroniD. PerruccioK. PiacentiniG. PifferiM. PignataroL. SitziaE. TersigniC. TorrettaS. TrambustiI. TrippellaG. ValentiniD. ValentiniS. VarricchioA. VergaM.C. ViciniC. ZeccaM. VillaniA. Prevention of recurrent respiratory infections.Ital. J. Pediatr.202147121110.1186/s13052‑021‑01150‑034696778
     [Google Scholar]
  5. HaybarH. PezeshkiS.M.S. SakiN. Evaluation of complete blood count parameters in cardiovascular diseases: An early indicator of prognosis?Exp. Mol. Pathol.201911010426710.1016/j.yexmp.2019.10426731194963
     [Google Scholar]
  6. AgnelloL. GiglioR.V. BivonaG. ScazzoneC. GambinoC.M. IaconaA. CiaccioA.M. Lo SassoB. CiaccioM. The value of a complete blood count (CBC) for sepsis diagnosis and prognosis.Diagnostics (Basel)20211110188110.3390/diagnostics1110188134679578
     [Google Scholar]
  7. TanL. Lymphopenia predicts disease severity of COVID-19: A descriptive and predictive study.Signal Transduct. Target. Ther.2020511332296011
     [Google Scholar]
  8. WangC. HorbyP.W. HaydenF.G. GaoG.F. A novel coronavirus outbreak of global health concern.Lancet20203951022347047310.1016/S0140‑6736(20)30185‑931986257
     [Google Scholar]
  9. EbobO.T. BabiakaS.B. Ntie-KangF. Natural products as potential lead compounds for drug discovery against SARS-CoV-2.Nat. Prod. Bioprospect.202111661162810.1007/s13659‑021‑00317‑w34515981
     [Google Scholar]
  10. DouradoD. FreireD.T. PereiraD.T. Amaral-MachadoL. N AlencarÉ. de BarrosA.L.B. EgitoE.S.T. Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials?Biomed. Pharmacother.202113911157810.1016/j.biopha.2021.11157833848774
     [Google Scholar]
  11. MinassiA. Sánchez-DuffhuesG. ColladoJ.A. MuñozE. AppendinoG. Dissecting the pharmacophore of curcumin. Which structural element is critical for which action?J. Nat. Prod.20137661105111210.1021/np400148e23742639
     [Google Scholar]
  12. BoroumandN. SamarghandianS. HashemyS.I. Immunomodulatory, anti-inflammatory, and antioxidant effects of curcumin.J. Herbmed. Pharmacol.20187421121910.15171/jhp.2018.33
     [Google Scholar]
  13. AllegraA. InnaoV. RussoS. GeraceD. AlonciA. MusolinoC. Anticancer activity of curcumin and its analogues: Preclinical and clinical studies.Cancer Invest.201735112210.1080/07357907.2016.124716627996308
     [Google Scholar]
  14. ZhangY. LiL. ZhangJ. Curcumin in antidepressant treatments: An overview of potential mechanisms, pre-clinical/clinical trials and ongoing challenges.Basic Clin. Pharmacol. Toxicol.2020127424325310.1111/bcpt.1345532544307
     [Google Scholar]
  15. ZahedipourF. HosseiniS.A. SathyapalanT. MajeedM. JamialahmadiT. Al-RasadiK. BanachM. SahebkarA. Potential effects of curcumin in the treatment of COVID-19 infection.Phytother. Res.202034112911292010.1002/ptr.673832430996
     [Google Scholar]
  16. BhattacharyyaS. Md Sakib HossainD. MohantyS. Sankar SenG. ChattopadhyayS. BanerjeeS. ChakrabortyJ. DasK. SarkarD. DasT. SaG. Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts.Cell. Mol. Immunol.20107430631510.1038/cmi.2010.1120305684
     [Google Scholar]
  17. DingX.Q. WuW.Y. JiaoR.Q. GuT.T. XuQ. PanY. KongL.D. Curcumin and allopurinol ameliorate fructose-induced hepatic inflammation in rats via miR-200a-mediated TXNIP/NLRP3 inflammasome inhibition.Pharmacol. Res.2018137647510.1016/j.phrs.2018.09.02130248460
     [Google Scholar]
  18. KaymazK. BeiklerT. Th17 cells and the IL-23/IL-17 axis in the pathogenesis of periodontitis and immune-mediated inflammatory diseases.Int. J. Mol. Sci.20192014339410.3390/ijms2014339431295952
     [Google Scholar]
  19. GongZ. ZhaoS. ZhouJ. YanJ. WangL. DuX. LiH. ChenY. CaiW. WuJ. Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1β production.Mol. Immunol.2018104111910.1016/j.molimm.2018.09.00430396035
     [Google Scholar]
  20. VezzaniA. FrenchJ. BartfaiT. BaramT.Z. The role of inflammation in epilepsy.Nat. Rev. Neurol.201171314010.1038/nrneurol.2010.17821135885
     [Google Scholar]
  21. HeQ. JiangL. ManS. WuL. HuY. ChenW. Curcumin reduces neuronal loss and inhibits the NLRP3 inflammasome activation in an epileptic rat model.Curr. Neurovasc. Res.201815318619210.2174/156720261566618073110022430062967
     [Google Scholar]
  22. ChenY. LiC. DuanS. YuanX. LiangJ. HouS. Curcumin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation in mice.Biomed. Pharmacother.201911810919510.1016/j.biopha.2019.10919531362244
     [Google Scholar]
  23. RenY. YangZ. SunZ. ZhangW. ChenX. NieS. Curcumin relieves paraquat-induced lung injury through inhibiting the thioredoxin interacting protein/NLR pyrin domain containing 3- mediated inflammatory pathway.Mol. Med. Rep.20192065032504010.3892/mmr.2019.1061231485636
     [Google Scholar]
  24. MehmoodR. MuhammedR.K. HussainS. SanaA. Evaluation of di-potassium and tri-potassium EDTA evacuated tubes for routine haematological testing.J. Clin. Lab. Anal.2018321e2218810.1002/jcla.2218828220977
     [Google Scholar]
  25. HussainS. MehmoodR. ArshadF.A. KhanS. Evaluation and comparison of stability and reliability of cbc parameters determined by using automatic celltac G MEK-9100 hematology analyzer during extended storage at 4°C.J. Clin. Res. Bioeth.2018921510.4172/2155‑9627.1000324
     [Google Scholar]
  26. Corporation, N.K., 1-31-4 Nishiochiai, Shinjuko-ku Tokyo 161-8560. Japan..
     [Google Scholar]
  27. PeiG. ZhangZ. PengJ. LiuL. ZhangC. YuC. MaZ. HuangY. LiuW. YaoY. ZengR. XuG. Renal involvement and early prognosis in patients with COVID-19 pneumonia.J. Am. Soc. Nephrol.20203161157116510.1681/ASN.202003027632345702
     [Google Scholar]
  28. IkeagwulonuR.C. A systematic review on use of liver function tests to assess association between liver injury and COVID-19 Disease.Int. J. Celiac. Dis.20208110116
     [Google Scholar]
  29. DingX. YuY. LuB. HuoJ. ChenM. KangY. LouJ. LiuZ. Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019.Clin. Chem. Lab. Med. (CCLM)20205881365137110.1515/cclm‑2020‑041132441666
     [Google Scholar]
  30. TianS. Longitudinal analysis of laboratory findings during the process of recovery for patients with COVID-19.medRxiv202010.1101/2020.04.04.20053280
     [Google Scholar]
  31. LaylaK.N. YeasminS. AzadA.B. ChowdhuryM.U. SultanaN. Muhammad Shazedur RahmanA.F.S. RahmanM.M. RafaR.L. Red blood cell profile in patients with mild, moderate and severe COVID-19.IMC J. Med. Sci.2021152263110.3329/imcjms.v15i2.55811
     [Google Scholar]
  32. MukherjeeA. GhoshR. FurmentM.M. Case report: COVID-19 associated renal infarction and ascending aortic thrombosis.Am. J. Trop. Med. Hyg.202010351989199210.4269/ajtmh.20‑086932918409
     [Google Scholar]
  33. ZhouH. ZhangZ. DobrininaM. DongY. KangZ. ChereshnevV. HuD. ZhangZ. ZhangJ. SarapultsevA. Urinalysis, but not blood biochemistry, detects the early renal impairment in patients with COVID-19.Diagnostics (Basel)202212360210.3390/diagnostics1203060235328155
     [Google Scholar]
  34. SantorielloD. KhairallahP. BombackA.S. XuK. KudoseS. BatalI. BaraschJ. RadhakrishnanJ. D’AgatiV. MarkowitzG. Postmortem kidney pathology findings in patients with COVID-19.J. Am. Soc. Nephrol.20203192158216710.1681/ASN.202005074432727719
     [Google Scholar]
  35. LiuY.M. XieJ. ChenM.M. ZhangX. ChengX. LiH. ZhouF. QinJ.J. LeiF. ChenZ. LinL. YangC. MaoW. ChenG. LuH. XiaX. WangD. LiaoX. YangJ. HuangX. ZhangB.H. YuanY. CaiJ. ZhangX.J. WangY. ZhangX. SheZ.G. LiH. Kidney function indicators predict adverse outcomes of COVID-19.Med (N. Y.)2021213848.e210.1016/j.medj.2020.09.00133043313
     [Google Scholar]
  36. YangX. JinY. LiR. ZhangZ. SunR. ChenD. Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis.Crit. Care202024135610.1186/s13054‑020‑03065‑432552872
     [Google Scholar]
  37. UribarriA. Núñez-GilI.J. AparisiA. Becerra-MuñozV.M. FeltesG. TrabattoniD. Fernández-RozasI. Viana-LlamasM.C. PepeM. CerratoE. Capel-AstruaT. RomeroR. Castro-MejíaA.F. El-BattrawyI. López-PaísJ. D’AscenzoF. Fabregat-AndresO. BardajíA. Raposeiras-RoubinS. MarínF. Fernández-OrtizA. MacayaC. EstradaV. HOPE COVID-19 Investigators Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry.J. Nephrol.202033473774510.1007/s40620‑020‑00790‑532602006
     [Google Scholar]
  38. GuptaS. CocaS.G. ChanL. MelamedM.L. BrennerS.K. HayekS.S. SutherlandA. PuriS. SrivastavaA. Leonberg-YooA. ShehataA.M. FlytheJ.E. RashidiA. SchenckE.J. GoyalN. HedayatiS.S. DyR. BansalA. AthavaleA. NguyenH.B. VijayanA. CharytanD.M. SchulzeC.E. JooM.J. FriedmanA.N. ZhangJ. SosaM.A. JuddE. VelezJ.C.Q. MallappallilM. RedfernR.E. BansalA.D. NeyraJ.A. LiuK.D. RenaghanA.D. ChristovM. MolnarM.Z. SharmaS. KamalO. BoatengJ.O. ShortS.A.P. AdmonA.J. SiseM.E. WangW. ParikhC.R. LeafD.E. and the STOP-COVID Investigators AKI treated with renal replacement therapy in critically ill patients with COVID-19.J. Am. Soc. Nephrol.202132116117610.1681/ASN.202006089733067383
     [Google Scholar]
  39. HachimY. HachimM.Y. NaeemK.B. HannawiH. Al SalmiI. Al-ZakwaniI. HannawiS. Kidney dysfunction among COVID-19 patients in the United Arab Emirates.Oman Med. J.2021361e22110.5001/omj.2020.9233585042
     [Google Scholar]
  40. BritoC.A. BarrosF.M. LopesE.P. Mechanisms and consequences of COVID-19 associated liver injury: What can we affirm?World J. Hepatol.202012841342210.4254/wjh.v12.i8.41332952870
     [Google Scholar]
  41. SainiR.K. SainiN. RamS. SoniS.L. SuriV. MalhotraP. KaurJ. VermaI. SharmaS. ZohmangaihiD. COVID-19 associated variations in liver function parameters: a retrospective study.Postgrad. Med. J.2022981156919710.1136/postgradmedj‑2020‑13893033184141
     [Google Scholar]
  42. MoutchiaJ. PokharelP. KerriA. McGawK. UchaiS. NjiM. GoodmanM. Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.PLoS One20201510e023980210.1371/journal.pone.023980233002041
     [Google Scholar]
  43. BzeiziK. AbdullaM. MohammedN. AlqamishJ. JamshidiN. BroeringD. Effect of COVID-19 on liver abnormalities: A systematic review and meta-analysis.Sci. Rep.20211111059910.1038/s41598‑021‑89513‑934012016
     [Google Scholar]
  44. Higuera-de la TijeraF. Servín-CaamañoA. Reyes-HerreraD. Flores-LópezA. Robiou-ViveroE.J.A. Martínez-RiveraF. Galindo-HernándezV. Chapa-AzuelaO. Chávez-MoralesA. Rosales-SalyanoV.H. Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19.Liver Res.202151212710.1016/j.livres.2021.01.00133520337
     [Google Scholar]
  45. PhippsM.M. BarrazaL.H. LaSotaE.D. SobieszczykM.E. PereiraM.R. ZhengE.X. FoxA.N. ZuckerJ. VernaE.C. Acute liver injury in COVID-19: Prevalence and association with clinical outcomes in a large US cohort.Hepatology202072380781710.1002/hep.3140432473607
     [Google Scholar]
/content/journals/emiddt/10.2174/1871530323666230314121123
Loading
Evaluation and Association of Hematological and Biochemical Parameters of Untreated COVID-19 Patients on the basis of Differences in Ethnicity and Curcumin as a Possible Treatment
Endocr Metab Immune Disord Drug Targets 25, 1282 (2025); https://doi.org/10.2174/1871530323666230314121123
/content/journals/emiddt/10.2174/1871530323666230314121123
/content/journals/emiddt/10.2174/1871530323666230314121123
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): COVID-19; creatinine; Curcumin; HGB; serum electrolytes; urea

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test